23:10 , Nov 2, 2016 |  BC Innovations  |  Distillery Therapeutics

Neurology

INDICATION: Parkinson’s disease (PD) In vitro and mouse studies suggest inhibiting LAG3 could help treat PD. In mouse primary cortical neurons treated with neurotoxic α-synuclein (SNCA) fibrils, LAG3 knockout or two anti-LAG3 mouse antibodies decreased...
07:00 , Oct 10, 2016 |  BC Week In Review  |  Company News

Boehringer Ingelheim, Sarah Cannon Research Institute deal

Boehringer and the institute partnered to develop Boehringer’s BI 754091 in combination with BI 754111 to treat cancer, including non-small cell lung cancer (NSCLC). BI 754091 is a mAb against PD-1 , and BI 754111...